Magdalena Eilenberg

Magdalena Eilenberg

Auto-generated profile, based on publicly available information

Magdalena Eilenberg

Division of General Surgery, Department of Surgery, Vienna Medical University, Vienna, Austria

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 July 2018 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
Daniel FelsenreichDaniel Felsenreich
Daniel Felsenreich
LLLukas M. Ladinig
Lukas M. Ladinig
PBPhilipp Beckerhinn
Philipp Beckerhinn
CSChristoph Sperker
Christoph Sperker
KSKatrin Schwameis
Katrin Schwameis
FLFelix B. Langer
Felix B. Langer

30 September 2017 in Obesity Surgery
Verified
Journal Article
Open access
PDF file
MEMagdalena Eilenberg
Magdalena Eilenberg
FLFelix B. Langer
Felix B. Langer
ABAndrea Beer
Andrea Beer
MTMichael Trauner
Michael Trauner
GPGerhard Prager
Gerhard Prager
KSKatharina Staufer
Katharina Staufer
Nonalcoholic fatty liver disease (NAFLD) occurs in up to 80% of patients with obesity. Current data suggest an improvement of NAFLD after established bariatric procedures.

1 October 2019 in United European Gastroenterology Journal
Verified
Journal Article
Closed access
KSKatharina Staufer
Katharina Staufer
EHEmina Halilbasic
Emina Halilbasic
WSWalter Spindelboeck
Walter Spindelboeck
MEMagdalena Eilenberg
Magdalena Eilenberg
GPGerhard Prager
Gerhard Prager
RSRudolf Stauber
Rudolf Stauber

5 December 2019 in Obesity Surgery
Verified
Journal Article
Open access
PDF file
Daniel FelsenreichDaniel Felsenreich
Daniel Felsenreich
FLFelix B. Langer
Felix B. Langer
CBChristoph Bichler
Christoph Bichler
MEMagdalena Eilenberg
Magdalena Eilenberg
JJJulia Jedamzik
Julia Jedamzik
GPGerhard Prager
Gerhard Prager
Background: Laparoscopic sleeve gastrectomy (SG) is the most frequently performed bariatric procedure today. While an increasing number of long-term studies report the occurrence of Barrett’s esophagus (BE) after SG, its treatment has not been studied, yet. Objectives: The aim of this study was to evaluate Roux-en-Y gastric bypass (RYGB) as treatment for BE and reflux after SG. Setting: University hospital setting, Austria Methods: This multi-center study includes all patients (n = 10) that were converted to RYGB due to BE after SG in Austria. The mean interval between SG and RYGB was 42.7 months. The follow-up after RYGB in this study was 33.4 months. Gastroscopy, 24 h pH-metry, and manometry were performed and patients were asked to complete the BAROS and GIQLI questionnaires. Results: Weight and BMI at the time of SG was 120.8 kg and 45.1 kg/m2. Eight patients (80.0%) went into remission of BE after the conversion to RYGB. Two patients had RYGB combined with hiatoplasty. The mean acid exposure time in 24 h decreased from 36.8 to 3.8% and the mean DeMeester score from 110.0 to 16.3. Patients scored 5.1 on average in the BAROS after conversion from SG to RYGB which denotes a very good outcome. Conclusions: RYGB is an effective therapy for patients with BE and reflux after SG. Its outcomes in the current study were BE remission in the majority of cases as well as a decrease in reflux activity. Further studies with larger cohorts are necessary to confirm these findings.

15 March 2019 in Obesity Facts
Verified
Journal Article
Open access
PDF file
Daniel FelsenreichDaniel Felsenreich
Daniel Felsenreich
GPGerhard Prager
Gerhard Prager
RKRonald Kefurt
Ronald Kefurt
MEMagdalena Eilenberg
Magdalena Eilenberg
JJJulia Jedamzik
Julia Jedamzik
FLFelix Benedikt Langer
Felix Benedikt Langer
Objective: Sleeve gastrectomy (SG) has recently become the most commonly applied bariatric procedure worldwide. Substantial regaining of weight or severe reflux might compromise quality of life (QOL) after SG in the long-term follow-up. Long-term data on patients’ QOL is limited, even though the persistent improvement in QOL is one of the aims of bariatric surgery. The objective of this study was to present patients’ QOL 10 years after SG. Methods: Of 65 SG patients with a follow-up of ≥10 years after SG who were asked to fill out the Bariatric Quality of Life Index (BQL) and Short Form 36 (SF36) questionnaires, 48 (74%) completed them. This multicenter study was performed in a university hospital setting in Austria. Results: The BQL score revealed nonsignificant differences between the patients with > 50% or < 50% excess weight loss (EWL). It did show significant differences between patients with and without any symptoms of reflux. Patients with < 50% EWL scored significantly lower in 3/8 categories of SF36. Patients suffering from reflux had significantly lower scores in all categories. Conclusions: EWL and symptomatic reflux impair patients’ long-term QOL after SG.

1 April 2020 in European Journal of Vascular and Endovascular Surgery
Verified
Journal Article
Closed access
MEMagdalena Eilenberg
Magdalena Eilenberg
MEMarjan Enayati
Marjan Enayati
DEDaniel Ehebruster
Daniel Ehebruster
CGChristian Grasl
Christian Grasl
IWIngrid Walter
Ingrid Walter
HBHelga Bergmeister
Helga Bergmeister